Jabra Enhance Select 500 vs Otofonix Groove

The Jabra Enhance Select 500 is a premium behind-the-ear OTC hearing aid priced at $1,995 that earns an A grade with a SoundScore of 4.2/5 in our lab testing. Ranking #13 of 65 OTC hearing aids tested, it places in the top 18% of its category. This 2024 release demonstrates strong speech-in-quiet performance, scoring 4.3/5—a full 1.50 points above the OTC category average. Speech-in-noise scores 1.8/5, which is above the category average by 0.31 points but remains low in absolute terms, reflecting a common challenge across OTC devices. Feedback handling is excellent at 4.6/5, slightly above the already-high category average. Music streaming scores 2.9/5, which is 0.98 points above the category average but only mixed in absolute terms—adequate for casual listening but not audiophile-quality. Own-voice comfort at 2.2/5 falls 0.31 points below the category average, which may be noticeable for users sensitive to how their voice sounds. The Enhance Select 500 supports iPhone and Android streaming, hands-free calling, and uses rechargeable batteries. It's a solid choice for those prioritizing clear speech in quieter environments and reliable feedback control. However, buyers seeking better value might consider the Jabra Enhance Select 300 or Lucid Engage, which offer similar sound performance at lower price points. This model has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.